The European Medicines Agency (EMA) is actively seeking new data partners with its new data analytics and real-world query interface, called DARWIN EU® This initiative aims to harness the power of real-world data to have advanced scientific research. It is also to inform regulatory decisions on medicines in the European Union (EU).

By analyzing real-world health data, DARWIN EU® supports scientific research on medicines and contributes to more informed regulatory decisions within the EU.

If your public or private organization has access to valuable real-world health data, we invite you to consider sending an expression of interest to become a potential new data partner in DARWIN EU®. Your participation will play an important role in increasing the quality and depth of real-world evidence on pharmaceuticals across the EU.

Key details:

Submission Deadline: Please submit your expression of interest by October 31, 2023.

Submission process: Detailed information on how to express your interest and join the DARWIN EU® network is available on the DARWIN EU Coordination Center website: How to join the network?